Conference Details - Faculty
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
13th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myelomas
The Fairmont Château Whistler
Whistler, British Columbia, Canada
February 11-15, 2009
Program Director
Andrew D. Zelenetz, MD, PhD
Chief, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, USA
Planning Committee
John C. Byrd, MD
D. Warren Brown Professor of Leukemia Research
Professor of Medicine and Medical Chemistry
Interim Co-Director, Division of Hematology and Oncology
Associate Director, Translational Research
The Ohio State University Comprehensive Cancer Center
Columbus, USA
Sundar Jagannath, MD
Professor of Medicine
New York Medical College
Chief, Multiple Myeloma and Transplant Program
St. Vincent’s Comprehensive Cancer Center
New York, USA
John P. Leonard, MD
The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medical College
Director, Clinical Research
Division of Hematology/Oncology
New York Weill Cornell Medical Center
Attending Physician
NewYork-Presbyterian Hospital
New York, USA
Charles Schiffer, MD
Professor of Medicine and Oncology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, USA
Faculty
James Berenson, MD
Medical and Scientific Director
Chief Executive Officer
Institute for Myeloma & Bone Cancer Research
West Hollywood, USA
Morey Blinder, MD
Associate Professor
Hematology Division
Department of Medicine
Department of Pathology and Immunology
Washington University School of Medicine
St. Louis, USA
Joseph M. Connors, MD
Lymphoma Tumor Group
British Columbia Cancer Agency
University of British Columbia
Vancouver, British Columbia, Canada
Michael W. N. Deininger, MD, PhD
Associate Professor
Section Head, Hematologic Malignancies
Division of Hematology and Medical Oncology
Oregon Health & Science University
Portland, USA
Sven de Vos, MD, PhD
Associate Director, Jonsson Comprehensive Cancer Center Hematopoietic Malignancies Program Area
Assistant Professor of Medicine
Division of Hematology and Oncology
David Geffen School of Medicine at UCLA
Los Angeles, USA
Madeleine Duvic, MD
Professor of Internal Medicine and Dermatology
Deputy Chairman, Department of Dermatology
Division of Internal Medicine
The University of Texas M. D. Anderson Cancer Center
Houston, USA
Harry Erba, MD, PhD
Associate Professor of Internal Medicine University of Michigan Health System Ann Arbor, USA
Alessandra Ferrajoli, MD
Assistant Professor of Medicine
Department of Leukemia
The University of Texas M. D. Anderson Cancer Center
Houston, USA
Jonathan Friedberg, MD
Associate Professor of Medicine and Oncology
Director, Hematological Malignancies Clinical Research
Chief, Hematology/Oncology Division
James P. Wilmot Cancer Center
University of Rochester
Rochester, USA
Randy Gascoyne, MD
Clinical Professor of Pathology
British Columbia Cancer Agency
University of British Columbia
Vancouver, Canada
Michael R. Grever, MD
Chairman and Charles Doan Professor of Medicine and Pharmacology
Department of Internal Medicine
The Ohio State University Medical Center
Columbus, USA
Fredrick Hagemeister, Jr, MD
Professor of Medicine
Department of Lymphoma and Myeloma
The University of Texas M. D. Anderson Cancer Center
Houston, USA
Paul Hamlin, MD
Assistant Member Attending
Medical Oncology
Lymphoma Service
Memorial Sloan-Kettering Cancer Center
Assistant Professor of Medicine
Department of Medicine
Joan & Sanford I. Weill Medical College of Cornell University
NewYork-Presbyterian Hospital
New York, USA
Thomas James Kipps, MD, PhD
Professor of Medicine
Deputy Director, Research Operations
Moores UCSD Cancer Center
La Jolla, USA
Thomas Lin, MD, PhD
Associate Professor of Internal Medicine
Division of Hematology and Oncology
The Ohio State University
Columbus, USA
Sagar Lonial, MD
Associate Professor
Emory University School of Medicine
Director, Translational Research
B-Cell Malignancy Program
Emory Winship Cancer Institute
Atlanta, USA
Ruben A. Mesa, MD
Associate Professor of Medicine
Mayo Clinic
Rochester, USA
Michael Pfreundschuh, MD
Professor and Director, Clinic of Internal Medicine
Universität des Saarlandes
Homburg, Germany
Linda Pilarski, PhD
Canada Research Chair
Department of Oncology
University of Alberta
Cross Cancer Institute
Edmonton, Canada
Barbara Pro, MD
Associate Professor of Medicine
The University of Texas M. D. Anderson Cancer Center
Houston, USA
Jerald P. Radich, MD
Medical Director, Research Trials Office
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Professor
University of Washington School of Medicine
Seattle, USA
Donna Reece, MD, PhD
Director, Program for Multiple Myeloma and Related Disease
Associate Professor of Medicine
Princess Margaret Hospital
Toronto, Canada
James Rubenstein, MD
Assistant Professor
Hematology/Oncology
University of California, San Francisco
San Francisco, USA
Jatin Shah, MD
Assistant Professor of Medicine
Department of Lymphoma and Myeloma
The University of Texas M. D. Anderson Cancer Center
Houston, USA
Jamile M. Shammo, MD, FASCP
Assistant Professor of Medicine and Pathology
Section of Hematology and Stem Cell Transplantation
Director, Hematology Oncology Fellowship Program
CME Course Director, Division of Hematology Oncology
Rush University Medical Center
Chicago, USA
Sonali M. Smith, MD
Assistant Professor
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, USA
Jerry L. Spivak, MD
Professor of Medicine and Oncology
Director, Center for the Chronic Myeloproliferative Disorders
The John Hopkins University School of Medicine
Baltimore, USA
David Steensma, MD
Associate Professor of Medicine, Hematology, and Oncology
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, USA
Wendy Stock, MD
Professor of Medicine
Section of Hematology/Oncology
Department of Medicine
Director, Leukemia Program
The University of Chicago
Chicago, USA
Martin S. Tallman, MD
Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Feinberg School of Medicine
Northwestern University
Co-Director, Hematologic Malignancies Program
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, USA
George G. Weiner, MD
C. E. Block Chair of Cancer Research
Director, Holden Comprehensive Cancer Center
Professor
Department of Internal Medicine
The University of Iowa
Iowa City, USA
William G. Wierda, MD, PhD
Associate Professor of Medicine and Internist
Department of Leukemia
The University of Texas M. D. Anderson Cancer Center
Houston, USA
Wyndham H. Wilson, MD, PhD
Senior Investigator and Chief, Lymphoma Therapeutics
Metabolism Branch
Chief, Lymphoma Clinic
Medicine Branch
Center for Cancer Research
National Cancer Institute, National Institutes of Health
Bethesda, USA
Jeffery Zonder, MD
Assistant Professor of Medicine
Division of Hematology-Oncology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, USA
Educational Grants
An educational grant for this activity was provided by:
- Genentech BioOncology/
Biogen Idec - Cephalon Oncology
- GlaxoSmithKline
- Novartis Oncology
- Bristol-Myers Squibb
- Eisai, Inc.
- Allos Therapeutics, Inc.
- Merck Oncology
- Biogen Idec
- Celgene Corporation